American Healthcare REIT, Inc. current report, 11 November 2016

Business Context and Reporting Period

This Form 8-K, filed on November 11, 2016, by Griffin-American Healthcare REIT IV, Inc. (American Healthcare REIT, Inc.), reports the entry into material definitive agreements. The filing details the assignment of asset purchase agreements for the acquisition of the Lafayette Assisted Living Portfolio in Lafayette, Louisiana.

Key Financial Metrics and Transaction Details

  • Aggregate Purchase Price: $16,500,000, plus closing costs.
  • Asset Scope: Two senior housing facilities comprising approximately 79,000 square feet of gross leasable area and 107 units.
  • Occupancy: 100% occupied at the time of the agreement.
  • Deposit Structure: Initial deposit of $25,000 per agreement; additional deposit of $75,000 per agreement due after the study period.
  • Financing Source: Funds raised through the company's initial public offering and debt financing.
  • Acquisition Fee: An acquisition fee based on the purchase price is anticipated to be paid to the company's advisor.

Material Changes and Agreement Terms

The company assumed rights under two asset purchase agreements originally dated March 31, 2016, which were subsequently amended five times. The most recent fifth amendment, executed on November 11, 2016, introduced critical conditions:

  • Mold Remediation Condition: Closing is contingent upon the company's sole discretion confirming satisfactory remediation of potential mold growth.
  • Termination Rights: The company retains the right to terminate and receive a refund of the deposit if mold issues are not satisfactorily remediated by February 1, 2017.
  • Closing Timeline: The anticipated closing date is the later of 10 days after mold remediation approval or November 30, 2016, subject to extension.
  • Holdback Provision: A percentage of the purchase price will be held back by the escrow agent at closing to cover potential losses.

Outlook, Risks, and Contingencies

Management anticipates closing the acquisition in the fourth quarter of 2016 but explicitly states no assurance can be given that the closing will occur within this timeframe or at all. The transaction is subject to substantial conditions, including the successful remediation of mold issues and the satisfaction of all conditions precedent. The filing notes that the company's sole remedy for losses (excluding fraud or bad faith) post-closing is recovery against the holdback amount.

Key Facts for Investor Verification

  • Confirmation of the successful remediation of mold issues as a condition precedent to closing.
  • Verification of the final closing date, given the potential for extension or termination by February 1, 2017.
  • Assessment of the company's ability to secure the necessary debt financing and utilize IPO proceeds as planned.
  • Review of the specific terms of the holdback escrow agreement to understand the extent of post-closing protection.
  • Confirmation that the 100% occupancy rate is maintained through the closing date.